(Q37955946)

25 August 2017

title

Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less (English)

1 reference

25 August 2017

Laurent Bélec

1

1 reference

25 August 2017

Jean-Paul Bonn

series ordinal

2

1 reference

25 August 2017

publication date

1 November 2011

1 reference

25 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

25 August 2017

volume

6

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1251-1260

1 reference

Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Impact of HIV-1 pol diversity on drug resistance and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

HIV viral load monitoring in resource-limited regions: optional or necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Scaling up antiretroviral treatment in resource-poor settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Simpler tests for immune cells could transform AIDS care in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Nano/Microfluidics for diagnosis of infectious diseases in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Defining treatment failure in resource-rich settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Long-term costs and health impact of continued global fund support for antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Advances in CD4 cell enumeration in resource-poor countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Affordable CD4 T-cell enumeration for resource-limited regions: a status report for 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Challenges in implementing CD4 testing in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Expansion of antiretroviral treatment to rural health centre level by a mobile service in Mumbwa district, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

The fragile environments of inexpensive CD4+ T-cell enumeration in the least developed countries: strategies for accessible support

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

XVII International AIDS Conference: From Evidence to Action - Basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

The marriage of science and optimized HIV care in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Advances in developing HIV-1 viral load assays for resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Challenges in implementing HIV load testing in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Monitoring of antiretroviral therapy in low-resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Economic evaluation of ART in resource-limited countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

HIV-1 resistance genotyping on dried serum spots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Performance of Immunologic Responses in Predicting Viral Load Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

Monitoring of antiretroviral therapy in low-resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.121

21 January 2018

Identifiers

DOI

10.2217/FMB.11.121

1 reference

25 August 2017

1 reference